| Human |
hsa_circ_UBAP2 |
- |
- |
osteosarcoma |
UBAP2 |
miR-143 |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
- |
lung adenocarcinoma |
UBAP2 |
miR-339-5p, miR-96-3p, miR-135b-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
glioma |
UBAP2 |
- |
Q
| DN |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0007367 |
- |
pancreatic adenocarcinoma |
UBAP2 |
hsa-miR-494 |
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003945 |
- |
osteosarcoma |
UBAP2 |
- |
M
| DN |
More |
| Human |
hsa_circ_UBAP2 |
- |
- |
clear cell renal carcinoma |
UBAP2 |
miR-148a-3p |
Q
| DN |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003141 |
- |
hepatocellular carcinoma |
UBAP2 |
miR-1827 |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
osteosarcoma |
UBAP2 |
miR-506-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
- |
osteosarcoma |
UBAP2 |
miR-641 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circRNA-UBAP2 |
ovarian cancer |
UBAP2 |
miR-382-5p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
- |
cervical cancer |
UBAP2 |
miR-361-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003496 |
circUBAP2 |
preeclampsia |
UBAP2 |
miR-1244 |
Q
| DN |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0008344 |
circ-UBAP2 |
glioma |
UBAP2 |
miR-1205, miR-382 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
osteosarcoma |
UBAP2 |
miR-204-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
hepatocellular carcinoma |
UBAP2 |
miR-4756 / hsa-miR-4756-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
non-small cell lung carcinoma |
UBAP2 |
miR-3182 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
prostate cancer |
UBAP2 |
miR-1244 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circRNA_104761 |
acute myocardial infarction |
UBAP2 |
hsa-miR-34c-5p, hsa-miR-449a, hsa-miR-449b-5p, hsa-miR-449c-5p, hsa-miR-370-3p, Hsa-miRNA-34a-5p, Hsa-miR-34b-5p, hsa-miR-34c-5p, Hsa-miRNA-449a, Hsa-miRNA-449b-5p, Hsa-miRNA-449c-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_UBAP2 |
- |
circRNA_104765 |
acute myocardial infarction |
UBAP2 |
hsa-miR-532-5p, hsa-miR-496, hsa-miR-767-5p, hsa-miR-589-5p, hsa-miR-188-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003945 |
circUBAP2 |
hepatocellular carcinoma |
UBAP2 |
miR-194-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003410 |
- |
hepatocellular carcinoma |
UBAP2 |
miR-139-3p |
Q
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003141 |
circUBAP2 |
thyroid cancer |
UBAP2 |
miR-370-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0001846 |
circ_0001846 |
osteoarthritis |
UBAP2 |
miR-149-5p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0008344 |
hsa_circRNA_0008344 |
glioma |
UBAP2 |
miR-638 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
CircUBAP2 |
prostate cancer |
UBAP2 |
miR-143 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
ovarian cancer |
UBAP2 |
miR-3692-5p, miR-6875-3p, miR-767-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0001847 |
circ-UBAP2 |
oral cavity squamous cell carcinoma |
UBAP2 |
miR-3188 |
Q
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
triple-negative breast carcinoma |
UBAP2 |
- |
Q
| DS |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
osteosarcoma |
UBAP2 |
miR-637 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
hsa_circMMD_007 |
lung adenocarcinoma |
UBAP2 |
miR-197-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003945 |
Circ_0003945 |
hepatocellular carcinoma |
UBAP2 |
hsa-miR-34c-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0007367 |
circUBAP2 |
cardiac arrest |
UBAP2 |
- |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
Circular RNA UBAP2 (circUBAP2) / CircUBAP2 |
triple-negative breast carcinoma |
UBAP2 |
miR-300 |
Q
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0086720 |
- |
gastric cancer |
UBAP2 |
hsa-miR-34c-5p, hsa-miR-449a, hsa-miR-449b-5p, hsa-miR-449c-5p |
Q
M
| DS |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0007367 |
- |
pancreatic ductal adenocarcinoma |
UBAP2 |
miR-6820-3p |
Q
H
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0001846 |
- |
malignant pancreatic neoplasm |
UBAP2 |
miR-204-3p |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003945 |
hsa_circRNA_104760 |
hepatocellular carcinoma |
UBAP2 |
hsa-miR-758-3p |
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0001847 |
circUBAP2(9,12) / circUBAP2 (9,12) |
nasopharyngeal carcinoma |
UBAP2 |
- |
Q
H
S
| DN |
More |
| Human |
hsa_circ_UBAP2 |
- |
circ-ubiquitin-associated protein 2 / circUBAP2 |
glioma |
UBAP2 |
- |
Q
| UN |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0001846 |
circ-UBAP2 |
triple-negative breast carcinoma |
UBAP2 |
miR-661 |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
Circular RNA UBAP2 / circUBAP2 |
esophageal squamous cell carcinoma |
UBAP2 |
miR-422a |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circular RNA UBAP2 / circUBAP2 |
ovarian cancer |
UBAP2 |
microRNA-144 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
- |
circRNA UBAP2 / circUBAP2 |
colorectal cancer |
UBAP2 |
miR-199a |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0086720 |
circRNA_104763 |
non-small cell lung carcinoma |
UBAP2 |
miR-375 |
Q
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003945 |
circUBAP2 |
hepatocellular carcinoma |
UBAP2 |
miR-1294 |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0086722 |
circ_0086722 |
prostate cancer |
UBAP2 |
miR-339-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0007367 |
circUBAP2 / Circular RNA UBAP2 |
cardiogenic shock |
UBAP2 |
- |
Q
| UN |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 / circRNA UBAP2 |
gastric cancer |
UBAP2 |
miR-300 |
Q
| DN |
More |
| Human |
hsa_circ_UBAP2 |
- |
circUBAP2 |
myelodysplastic syndrome |
UBAP2 |
- |
S
| UP |
More |
| Human |
hsa_circ_UBAP2 |
hsa_circ_0003141 |
circRNA ubiquitin-associated protein 2 / circUBAP2 / Circular RNA UBAP2 |
urinary bladder carcinoma |
UBAP2 |
miR-496 |
Q
| UP |
More |